Nefazodone hydrochloride, >=98% (HPLC), solid

Descriptions

Biochem/physiol Actions

Novel antidepressant; mixed 5-HT_2A serotonin receptor antagonist/serotonin uptake inhibitor.

Features and Benefits

This compound was developed by Bristol-Myers Squibb. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Packaging

10, 50 mg in glass bottle

Specifications

Colour	white
Quality Level	100
InChI key	DYCKFEBIOUQECE-UHFFFAOYSA-N
InChI	1S/C25H32ClN5O2.ClH/c1-2-24-27-31(25(32)30(24)18-19-33-23-10-4-3-5-11-23)13-7-12-28-14-16-29(17-15-28)22-9-6-8-21(26)20-22;/h3-6,8-11,20H,2,7,12-19H2,1H3;1H
Manufacturer	SIGMA-ALDRICH
Form	solid
Assay	≥98% (HPLC)